Skip to main content
. Author manuscript; available in PMC: 2014 Jun 1.
Published in final edited form as: Inflamm Bowel Dis. 2013 Jun;19(7):1514–1517. doi: 10.1097/MIB.0b013e318281f4f1

Figure 1. Actual Costs of Infliximab at LPCH.

Figure 1

Annual infliximab expenditure at LPCH during 2006–2011. Estimated by drug expenditure, pediatric gastroenterology and rheumatology comprised majority of infliximab utilization. Total estimated infliximab use by all medical services at LPCH increased since 2007.